Morgan Stanley’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4M | Buy |
237,605
+65,523
| +38% | +$2.86M | ﹤0.01% | 3414 |
|
|
2025
Q1 | $4.71M | Sell |
172,082
-67,681
| -28% | -$1.85M | ﹤0.01% | 3974 |
|
|
2024
Q4 | $9.65M | Sell |
239,763
-248,314
| -51% | -$9.99M | ﹤0.01% | 3446 |
|
|
2024
Q3 | $23.1M | Sell |
488,077
-143,661
| -23% | -$6.8M | ﹤0.01% | 2661 |
|
|
2024
Q2 | $18.9M | Buy |
631,738
+84,598
| +15% | +$2.53M | ﹤0.01% | 2730 |
|
|
2024
Q1 | $22M | Sell |
547,140
-335,416
| -38% | -$13.5M | ﹤0.01% | 2592 |
|
|
2023
Q4 | $22.5M | Buy |
882,556
+543,228
| +160% | +$13.8M | ﹤0.01% | 3229 |
|
|
2023
Q3 | $4.72M | Sell |
339,328
-66,577
| -16% | -$925K | ﹤0.01% | 3793 |
|
|
2023
Q2 | $9.33M | Buy |
405,905
+79,583
| +24% | +$1.83M | ﹤0.01% | 3233 |
|
|
2023
Q1 | $9.67M | Buy |
326,322
+88,520
| +37% | +$2.62M | ﹤0.01% | 3179 |
|
|
2022
Q4 | $5.94M | Buy |
237,802
+65,052
| +38% | +$1.62M | ﹤0.01% | 3597 |
|
|
2022
Q3 | $3.76M | Sell |
172,750
-161,399
| -48% | -$3.51M | ﹤0.01% | 3928 |
|
|
2022
Q2 | $6.58M | Buy |
334,149
+148,666
| +80% | +$2.93M | ﹤0.01% | 3503 |
|
|
2022
Q1 | $7.85M | Buy |
185,483
+103,358
| +126% | +$4.37M | ﹤0.01% | 3192 |
|
|
2021
Q4 | $5.21M | Sell |
82,125
-5,436
| -6% | -$345K | ﹤0.01% | 3674 |
|
|
2021
Q3 | $5.14M | Buy |
87,561
+23,873
| +37% | +$1.4M | ﹤0.01% | 3658 |
|
|
2021
Q2 | $3.09M | Sell |
63,688
-287,052
| -82% | -$13.9M | ﹤0.01% | 4261 |
|
|
2021
Q1 | $13.6M | Buy |
350,740
+333,257
| +1,906% | +$13M | ﹤0.01% | 2328 |
|
|
2020
Q4 | $1.08M | Buy |
17,483
+12,856
| +278% | +$797K | ﹤0.01% | 4617 |
|
|
2020
Q3 | $149K | Buy |
+4,627
| New | +$149K | ﹤0.01% | 5247 |
|